Clindamycin - Pfizer

Drug Profile

Clindamycin - Pfizer

Alternative Names: Cleocin; Cleocin cream; Cleocin® Vaginal Ovules; Clindamycin vaginal cream; Clindamycin vaginal ovule

Latest Information Update: 29 Apr 2003

Price : $50

At a glance

  • Originator Pfizer
  • Class Antibacterials; Lincosamides; Small molecules
  • Mechanism of Action Protein 50S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Bacterial vaginosis

Most Recent Events

  • 22 Apr 2003 A study has been added to the Women's Health therapeutic trials section
  • 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer
  • 27 Sep 2001 A clinical study has been added to the adverse events and Women's Health and Bacterial Infections pharmacodynamics sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top